VistaGen Therapeutics Inc. (VTGN) Slipped -5.09% or -0.06 To Price $1.12 On Thursday


VistaGen Therapeutics Inc. (VTGN) slipped -5.09% or -0.06 to $1.12. It is about 990991 shares traded, which is 34.61% compare to the average total volume 2.86 million. The market cap of VTGN is $24.47 million. The year to date change is 1.72%. The 52 week price range is from $0.69 to $3.9. Price of VTGN have changed 2.61% during last week. It have changed 51.28% over last month, -26.25% over last 3 months, -33.33% over last 6 months and -68.39% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for VTGN is 1.02. It is -8.93% below current price. The 200-day Moving Averages for VTGN is 1.62. It is 44.64% above current price. The 52-week High is 3.9. It is 248.21% from the current price. The 52-week Low is 0.69. It is -38.39% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of VTGN is 0.18 on 2017-12-15. Short % to float is 3.22%. There are some statistics of VTGN. It is has market cap $24.47 million. The share outstanding is 21.85 million. The average volume is 2.86 million. It has 6.31M cash and 366700 in debt. The percent of top 15 Institution holding is 54.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of VTGN is -1115.63%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of VTGN is -278.60%.


Tags:

Share this post